A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients

Stopped The sponsor decided to terminate the study following an FDA request of a partial clinical hold.

Conditions

• RRMM

Interventions

• DRUG: Melphalan
• DRUG: Dexamethasone

Sponsor

Oncopeptides AB